Kenneth D. Eichenbaum
CIK: 0002024404
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 24, 2026FEMY
FEMASYS INC
Award(A)DirectStock Option (Right to Buy)
880 shares- - May 12, 2026INFU
InfuSystem Holdings, Inc
Award(A)DirectStock Option (right to buy)
24.9K shares- - Mar 19, 2026FEMY
FEMASYS INC
Award(A)DirectSeries D-1 Warrants
102.4K shares- - Mar 18, 2026FEMY
FEMASYS INC
Award(A)DirectStock Option (Right to Buy)
35.2K shares- - May 28, 2025INFU
InfuSystem Holdings, Inc
Purchase(P)Direct2K shares at avg. $5.18$10K - May 16, 2025INFU
InfuSystem Holdings, Inc
Award(A)DirectStock Option (right to buy)
39.6K shares- - Sep 23, 2024INFU
InfuSystem Holdings, Inc
Purchase(P)Direct4K shares at avg. $5.89$24K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  FEMY FEMASYS INC | Award(A) Stock Option (Right to Buy) | 880 | - | - | Direct |
| May 12, 2026 |  INFU InfuSystem Holdings, Inc | Award(A) Stock Option (right to buy) | 24,890 | - | - | Direct |
| Mar 19, 2026 | FEMY FEMASYS INC | Award(A) Series D-1 Warrants | 102,366 | - | - | Direct |
| Mar 18, 2026 | FEMY FEMASYS INC | Award(A) Stock Option (Right to Buy) | 35,200 | - | - | Direct |
| May 28, 2025 | INFU InfuSystem Holdings, Inc | Purchase(P) | 2,000 | $5.18 | $10,360 | Direct |
| May 16, 2025 | INFU InfuSystem Holdings, Inc | Award(A) Stock Option (right to buy) | 39,588 | - | - | Direct |
| Sep 23, 2024 | INFU InfuSystem Holdings, Inc | Purchase(P) | 4,000 | $5.89 | $23,560 | Direct |
1-7 of 7 transactions
About Eichenbaum Kenneth D.
Eichenbaum Kenneth D. (SEC CIK 0002024404) files insider reports with the SEC as Director of FEMASYS INC (FEMY) and Director of InfuSystem Holdings, Inc (INFU).
Signal8 holds 8 ownership filings by Eichenbaum Kenneth D. (1 Form 3, 7 Form 4), filed between Sep 25, 2024 and Aug 11, 2026. Those filings report 7 transactions, from Sep 23, 2024 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Eichenbaum Kenneth D.'s filings is in SUWANEE, GA.
Recent filings by Eichenbaum Kenneth D.
- Jun 24, 2026: Grant or award of FEMY derivative securities (Form 4, code A).
- May 12, 2026: Grant or award of INFU derivative securities (Form 4, code A).
- Mar 19, 2026: Grant or award of FEMY derivative securities (Form 4, code A).
- Mar 18, 2026: Grant or award of FEMY derivative securities (Form 4, code A).
- May 28, 2025: Open-market purchase of INFU shares (Form 4, code P).
Other insiders filing for FEMASYS INC (FEMY)
- Uzialko Edward R, Director
- Milnes Alistair, Director
- Larsen Charles, Director
- Mifek Jeffrey Gerald, Chief Clinical-Medical Affairs
- Sipos Jeremy Alexander, Chief Technology Officer
- Canning John Charles, Chief Operating Officer